Experimental Gene-Editing Drug Shows Promise for Long-Term Heart Disease Prevention

A small trial of an experimental gene-editing drug demonstrated that a single infusion could significantly reduce LDL cholesterol long-term, potentially offering a "curative" approach to heart disease prevention.